98 related articles for article (PubMed ID: 23994466)
1. Application of electrolysis for inactivation of an antiviral drug that is one of possible selection pressure to drug-resistant influenza viruses.
Kobayashi T; Hirose J; Wu H; Sano K; Katsumata T; Tsujibo H; Nakano T
J Virol Methods; 2013 Dec; 194(1-2):154-60. PubMed ID: 23994466
[TBL] [Abstract][Full Text] [Related]
2. Published sequences do not support transfer of oseltamivir resistance mutations from avian to human influenza A virus strains.
Norberg P; Lindh M; Olofsson S
BMC Infect Dis; 2015 Mar; 15():162. PubMed ID: 25887656
[TBL] [Abstract][Full Text] [Related]
3. Characterization of oseltamivir-resistant influenza A(H1N1)pdm09 viruses in Taiwan in 2009-2011.
Yang JR; Huang YP; Chang FY; Hsu LC; Huang HY; Pan YT; Lin YC; Wu HS; Liu MT
J Med Virol; 2013 Mar; 85(3):379-87. PubMed ID: 23280715
[TBL] [Abstract][Full Text] [Related]
4. Oseltamivir-resistant influenza viruses isolated in South Korea from 2005 to 2010.
Cho HG; Choi JH; Lee HK; Mun SK; Lee JB; Jho EH; Kang C; Lim YH
Arch Virol; 2013 Nov; 158(11):2365-70. PubMed ID: 23690054
[TBL] [Abstract][Full Text] [Related]
5. Pandemic pharmaceutical dosing effects on wastewater treatment: no adaptation of activated sludge bacteria to degrade the antiviral drug oseltamivir (Tamiflu®) and loss of nutrient removal performance.
Slater FR; Singer AC; Turner S; Barr JJ; Bond PL
FEMS Microbiol Lett; 2011 Feb; 315(1):17-22. PubMed ID: 21133989
[TBL] [Abstract][Full Text] [Related]
6. The environmental fate of the antiviral drug oseltamivir carboxylate in different waters.
Bartels P; von Tümpling W
Sci Total Environ; 2008 Nov; 405(1-3):215-25. PubMed ID: 18675443
[TBL] [Abstract][Full Text] [Related]
7. Neuraminidase inhibitor resistance in influenza viruses and laboratory testing methods.
Nguyen HT; Fry AM; Gubareva LV
Antivir Ther; 2012; 17(1 Pt B):159-73. PubMed ID: 22311680
[TBL] [Abstract][Full Text] [Related]
8. Rapid and simple detection of Tamiflu-resistant influenza virus: Development of oseltamivir derivative-based lateral flow biosensor for point-of-care (POC) diagnostics.
Hwang SG; Ha K; Guk K; Lee DK; Eom G; Song S; Kang T; Park H; Jung J; Lim EK
Sci Rep; 2018 Aug; 8(1):12999. PubMed ID: 30158601
[TBL] [Abstract][Full Text] [Related]
9. Influenza virus susceptibility and resistance to oseltamivir.
Aoki FY; Boivin G; Roberts N
Antivir Ther; 2007; 12(4 Pt B):603-16. PubMed ID: 17944268
[TBL] [Abstract][Full Text] [Related]
10. Analysis and assay of oseltamivir-resistant mutants of influenza neuraminidase via direct observation of drug unbinding and rebinding in simulation.
Woods CJ; Malaisree M; Long B; McIntosh-Smith S; Mulholland AJ
Biochemistry; 2013 Nov; 52(45):8150-64. PubMed ID: 24128064
[TBL] [Abstract][Full Text] [Related]
11. Infiltration of water molecules into the oseltamivir-binding site of H274Y neuraminidase mutant causes resistance to oseltamivir.
Park JW; Jo WH
J Chem Inf Model; 2009 Dec; 49(12):2735-41. PubMed ID: 19957991
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility of human influenza viruses from Australasia and South East Asia to the neuraminidase inhibitors zanamivir and oseltamivir.
Hurt AC; Barr IG; Hartel G; Hampson AW
Antiviral Res; 2004 Apr; 62(1):37-45. PubMed ID: 15026200
[TBL] [Abstract][Full Text] [Related]
13. Mutation-induced loop opening and energetics for binding of tamiflu to influenza N8 neuraminidase.
Kar P; Knecht V
J Phys Chem B; 2012 May; 116(21):6137-49. PubMed ID: 22553951
[TBL] [Abstract][Full Text] [Related]
14. Oseltamivir carboxylate, the active metabolite of oseltamivir phosphate (Tamiflu), detected in sewage discharge and river water in Japan.
Ghosh GC; Nakada N; Yamashita N; Tanaka H
Environ Health Perspect; 2010 Jan; 118(1):103-7. PubMed ID: 20056566
[TBL] [Abstract][Full Text] [Related]
15. Allele-specific conventional reverse-transcription polymerase chain reaction as a screening assay for discriminating influenza a H1N1 (H275Y) oseltamivir-resistant and wild-type viruses.
Ngai KL; Lam WY; Lee N; Leung TF; Hui DS; Chan PK
J Med Virol; 2010 Aug; 82(8):1295-8. PubMed ID: 20572070
[TBL] [Abstract][Full Text] [Related]
16. Emergence of H274Y oseltamivir-resistant A(H1N1) influenza viruses in Japan during the 2008-2009 season.
Baranovich T; Saito R; Suzuki Y; Zaraket H; Dapat C; Caperig-Dapat I; Oguma T; Shabana II; Saito T; Suzuki H;
J Clin Virol; 2010 Jan; 47(1):23-8. PubMed ID: 19962344
[TBL] [Abstract][Full Text] [Related]
17. Evolution of drug resistance in multiple distinct lineages of H5N1 avian influenza.
Hill AW; Guralnick RP; Wilson MJ; Habib F; Janies D
Infect Genet Evol; 2009 Mar; 9(2):169-78. PubMed ID: 19022400
[TBL] [Abstract][Full Text] [Related]
18. Oseltamivir-resistant influenza viruses circulating during the first year of the influenza A(H1N1) 2009 pandemic in the Asia-Pacific region, March 2009 to March 2010.
Hurt AC; Deng YM; Ernest J; Caldwell N; Leang L; Iannello P; Komadina N; Shaw R; Smith D; Dwyer DE; Tramontana AR; Lin RT; Freeman K; Kelso A; Barr IG
Euro Surveill; 2011 Jan; 16(3):. PubMed ID: 21262183
[TBL] [Abstract][Full Text] [Related]
19. Oseltamivir-resistant pandemic influenza a (H1N1) 2009 viruses in Spain.
Ledesma J; Vicente D; Pozo F; Cilla G; Castro SP; Fernández JS; Ruiz MP; Navarro JM; Galán JC; Fernández M; Reina J; Larrauri A; Cuevas MT; Casas I; Breña PP;
J Clin Virol; 2011 Jul; 51(3):205-8. PubMed ID: 21592854
[TBL] [Abstract][Full Text] [Related]
20. Neuraminidase amino acids 149 and 347 determine the infectivity and oseltamivir sensitivity of pandemic influenza A/H1N1 (2009) and avian influenza A/H5N1.
Yongkiettrakul S; Nivitchanyong T; Pannengpetch S; Wanitchang A; Jongkaewwattana A; Srimanote P
Virus Res; 2013 Aug; 175(2):128-33. PubMed ID: 23639424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
